Fluticasone Propionate News
Fluticasone Propionate currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Fluticasone Propionate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Seffalair Spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled...
- Evidence level: L5
- Predicted indications (20):
- atopic eczema (99.7%)
- dermatitis, atopic (99.3%)
- 2-hydroxyethyl methacrylate sensitization (98.6%)
- occupational dermatitis (97.3%)
- allergic asthma (97.2%)
- intrinsic asthma (96.9%)
- seborrheic dermatitis (96.7%)
- contact dermatitis (96.7%)
- vulvar inverted follicular keratosis (96.4%)
- seborrheic keratosis (96.3%)
- alopecia mucinosa (96.1%)
- telogen effluvium (96.0%)
- lichen disease (96.0%)
- alopecia areata (95.9%)
- Quinquaud's folliculitis decalvans (95.4%)
- atopic dermatitis (95.3%)
- polyp of vocal cord (95.0%)
- hereditary hypotrichosis with recurrent skin vesicles (95.0%)
- polyp of middle ear (94.9%)
- epulis (94.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.